Immunization

The company plans to submit data to the European Medicines Agency, FDA, and other global regulators.

Michael Hogue joins Ed Cohen and John Beckner to dig deeper into vaccine hesitancy, boosters, and other topics in the immunization space.

The difference between individuals who were vaccinated and had the infection were higher at different intervals than for those who were unvaccinated.

A new poll shows that this year 64% of individuals between aged 50 and 64 years say they already got or are likely to get their influenza shots up from 54% last year.

Pharmacists and technicians have an opportunity to prove their value as immunizers now that the Pfizer-BioNTech COVID-19 vaccine has been authorized for use in children ages 5 to 11.

Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.

The results of a study show that individuals who received 3 doses of the BNT162b2 vaccine had a 93% lower risk of hospitalization than those who had just 2.

Among those who were infected with the delta variant (126), 25% were fully immunized and 38% were unvaccinated, study results show.

Overall vaccine efficacy was 54.6%, which met the pre-specified endpoint for success and showed benefit across 3 influenza seasons and all 8 countries.

Linda Mendonça, DNP, RN, PHNA-BC, president of the National Association of School Nurses, discusses a new poll released by the COVID-19 Vaccine Education and Equity Project and the National Association of School Nurses about parents’ plans to vaccinate their school-aged children.

Mild dengue fever causes a high fever and flu-like symptoms.

The Keep Up the Rates campaign is aiming to encourage patients to catch up on routine vaccinations that might have been missed or delayed due to the COVID-19 pandemic.

Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.

The success of the COVID-19 messenger RNA (mRNA) vaccines from Pfizer/BioNTech and Moderna has given many HIV advocates hope that a preventive mRNA vaccine is on the horizon.

Public recognition of their role has increased exponentially during the COVID-19 pandemic.

Symptoms of bird flu include cough, fever, sore throat, muscle aches, headache, and shortness of breath.

New study results show that single-dose vaccination may benefit populations with limited supplies.

Melissa Pein, a pharmacy technician supervisor at Children’s Mercy Kansas City Hospital, discusses her CPhT 2021 conference presentation regarding pharmacy technicians and the role they play in vaccinations

Clinical testing of COVID-19 vaccine efficacy has led to the first FDA-approved COVID-19 vaccine, Comirnaty.

Survey results from COVID-19 Vaccine Education and Equity Project shows desire to protect kids from getting the coronavirus.

Study results show that individuals who were vaccinated against the flu were 37% less likely to be hospitalized and 82% less likely to be admitted to the ICU that those who were unvaccinated.

The vaccine is used to prevent cervical cancer and other cancers, such as vulvar, vaginal, and oropharyngeal.

The agency has a 2-day meeting scheduled for this week for an independent advisory panel to discuss the available data.

New study results show that previously infected patients had molecular markers that suggested that immune cells could last longer and migrate more effectively to the respiratory tract.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Anna Legreid-Dopp, PharmD, Senior Director of Clinical Guidelines and Quality Improvement at the American Society of Health-System Pharmacists discusses Pfizer’s request to approve their COVID-19 vaccine for children 5 to 11.

A town hall meeting with representatives from the agencies emphasized the effectiveness and likelihood of getting a third dose of the vaccine.